Clinical Trial Update: A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled trial evaluating Antroquinonol in patients with chronic hepatitis B; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Antroquinonol (antroquinonol)

Snippet

Sponsor: Cheng-Chung Wei | Conditions: Chronic Hepatitis B | Phase 2 | Status: UNKNOWN